Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.
Bryant
J
J
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX, UK.
Cave
C
C
Mihaylova
B
B
Chase
D
D
McIntyre
L
L
Gerard
K
K
Milne
R
R
D002648:Child; D003362:Cost-Benefit Analysis; D019382:Human Growth Hormone / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011218:Prader-Willi Syndrome / Q000188:drug therapy; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013222:State Medicine; D016896:Treatment Outcome; D014424:Turner Syndrome / Q000188:drug therapy; D006113:United Kingdom
D019382:Human Growth Hormone